Multiple Sclerosis Clinical Trial
Official title:
Cognitive-motor Interference in Persons With MS: Dual Task Assessment and Training - A Multi-center Study
Dual tasking such as walking while talking on the phone or while remembering a shopping list
is very frequently required in everyday life. Cognitive-motor interference occurs when the
performance capacity of a motor or cognitive task decreases when both are performed
simultaneously (dual task) compared to single task execution being the so-called dual task
cost (DTC). Over the past five years, in MS, (pilot) studies have been conducted in order to
investigate the presence and magnitude of the CMI during walking. It was shown that, even in
the early stages of the disease, when walking speed is not affected as a single motor task,
pwMS slow down more than healthy controls when performing DT walking. Studies have not yet
investigated the impact of the complexity of the motor task, on the DTC. Across studies, many
different types of cognitive distractors were applied without any documentation of
psychometric properties, such as test-retest reliability, making it not yet suited as
experimental outcome measure. Results have also focused on the effects of DT on walking
performance, while the performance of the cognitive task was rarely assessed. Also, the
majority of studies did not document the cognitive function level of pwMS or even excluded
patients with cognitive deficits. As such, the relation between cognitive deficits and dual
task (cognitive-motor) performance is unclear.
Motor and cognitive impairment are currently also treated separately whereas real life
performance very often requiring an integrated motor and cognitive function. So far, no
studies in MS have investigated the effects of physical or cognitive exercises on DT
performances, or investigated effects of integrated cognitive-motor dual task training (DTT).
In elderly and other neurological conditions, superior effects of dual task training (DTT) on
gait training have been suggested, but the evidence is not robust yet. All these studies
suggest the feasibility of DTT on gait improvement and fall risk reduction, but further
insights on factors identifying responders, and differential effect of cognitive distractors
needs further elucidation.
This research consist of two parts that aim to investigate:
Part 1: Assessment
1. the magnitude of the dual task cost according to different types of cognitive
distractors (information processing, memory, attention, etc.),
2. its reliability as experimental outcome measure and
3. its association with factors as severity of cognitive or motor dysfunction, quality of
life and fatigue.
Part 2: Intervention
1. the effectiveness of cognitive-motor DT-based training programs compared to single
modality training, on DT and ST performances (cognition and mobility)
2. whether dual task learning effects transfer to improvements in daily life and are
sustained for 4 weeks without training
3. which patient profiles benefit most from the integrated cognitive-motor training
4. feasibility and usefulness of an adaptive, interactive ICT-guided DTT system.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |